Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 19Other hematologic neoplasm 16Plasma cell 11Myeloid 11Dermatologic 2Classical hematology 2Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 9Leukemia, Myelomonocytic, Chronic 8Anemia, Refractory, with Excess of Blasts 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 5Lymphoma, Non-Hodgkin 5Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Anemia, Refractory 4Primary Myelofibrosis 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Chronic-Phase 3Leukemia 3Thrombocythemia, Essential 2Polycythemia Vera 2Multiple Myeloma 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Prolymphocytic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Waldenstrom Macroglobulinemia 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Prolymphocytic, T-Cell 1

Interventions

Cyclophosphamide 34fludarabine phosphate 32Mycophenolic Acid 27Whole-Body Irradiation 21Peripheral Blood Stem Cell Transplantation 21Tacrolimus 19Melphalan 18Cyclosporine 17fludarabine 16Busulfan 16Antilymphocyte Serum 16Filgrastim 12Cord Blood Stem Cell Transplantation 9Methotrexate 8Radiotherapy 7Methylprednisolone 6Granulocyte Colony-Stimulating Factor 6Sirolimus 5Rituximab 5Epoetin Alfa 5Etoposide 4Cytarabine 4Alemtuzumab 4thymoglobulin 3Therapeutics 3Stem Cell Transplantation 3Darbepoetin alfa 3Clofarabine 3CT-P10 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hodgkin Disease × Cyclosporins × Classical hematology × Clear all
NCT00027820 2019-12-20

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
106 enrolled
Classical hematologyGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01251575 2019-12-09

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Completed
77 enrolled 10 charts
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡